Antimicrobial stewardship programs (ASPs): The devil is in the details

Virulence

Volumn 4, Issue 2, 2013, Pages 147-149

  Cunha, Cheston B ^a   Varughese, Christy A ^b   Mylonakis, Eleftherios ^a  

^a BROWN UNIVERSITY   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; ANTIINFECTIVE AGENT; AZTREONAM; BETA LACTAM; CARBAPENEM; CEFOPERAZONE; CEFOTAXIME; CEFTAZIDIME; CEFTIZOXIME; CEFTRIAXONE; CEPHALOSPORIN; CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; DAPTOMYCIN; DOXYCYCLINE; FOSFOMYCIN; GATIFLOXACIN; GENTAMICIN; IMIPENEM; LATAMOXEF; MINOCYCLINE; NITROFURANTOIN; PENICILLIN DERIVATIVE; QUINOLONE; TELITHROMYCIN; TROVAFLOXACIN; UNINDEXED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; DIFFERENTIAL DIAGNOSIS; DRUG COST; DRUG EFFECT; EVIDENCE BASED MEDICINE; HEALTH PROGRAM; HOSPITAL COST; HOSPITAL MANAGEMENT; HUMAN; INFECTION; INFECTION CONTROL; KLEBSIELLA PNEUMONIAE INFECTION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MULTIDRUG RESISTANCE; NONHUMAN; PHARMACY; PNEUMOCOCCAL INFECTION; PSEUDOMONAS INFECTION; THERAPEUTIC MISCONCEPTION; VANCOMYCIN RESISTANT ENTEROCOCCUS;

EID: 84874211426     PISSN: 21505594     EISSN: 21505608     Source Type: Journal    
DOI: 10.4161/viru.23856     Document Type: Article

References (28)

1. Boucher HW, Talbot GH, Bradley JS, Edwards JE, Gilbert D, Rice LB, et al. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis 2009; 48:1-12; PMID:19035777; http://dx.doi.org/10.1086/595011
2. Nemchenko A. Infographic: Antimicrobial Stewardship. Virulence 2013; 4; In press; PMID:23324540; http://dx.doi.org/10.4161/viru.23630
3. Johannsson B, Beekmann SE, Srinivasan A, Hersh AL, Laxminarayan R, Polgreen PM. Improving antimicrobial stewardship: the evolution of programmatic strategies and barriers. Infect Control Hosp Epidemiol 2011; 32:367-74; PMID:21460488; http://dx.doi.org/10.1086/658946
4. Owens RC Jr., Shorr AF, Deschambeault AL. Antimicrobial stewardship: shepherding precious resources. Am J Health Syst Pharm 2009; 66(Suppl 4):S15-22; PMID:19502223; http://dx.doi.org/10.2146/090087c
5. Lesprit P, Brun-Buisson C. Hospital antibiotic stewardship. Curr Opin Infect Dis 2008; 21:344-9; PMID:18594284; http://dx.doi.org/10.1097/QCO.0b013e3283013959
6. Allerberger F, Mittermayer H. Antimicrobial stewardship. Clin Microbiol Infect 2008; 14:197-9; PMID:18190577; http://dx.doi.org/10.1111/j.1469-0691.2007.01929.x
7. Septimus EJ, Owens RC Jr. Need and potential of antimicrobial stewardship in community hospitals. Clin Infect Dis 2011; 53(Suppl 1):S8-14; PMID:21795728; http://dx.doi.org/10.1093/cid/cir363
8. Ohl CA, Luther VP. Antimicrobial stewardship for inpatient facilities. J Hosp Med 2011; 6(Suppl 1):S4-15; PMID:21225949; http://dx.doi.org/10.1002/jhm.881
9. Berrington A. Antimicrobial prescribing in hospitals: be careful what you measure. J Antimicrob Chemother 2010; 65:163-8; PMID:19884120; http://dx.doi.org/10.1093/jac/dkp399
10. Bevilacqua S, Demoré B, Boschetti E, Doco-Lecompte T, May I, May T, et al. 15 years of antibiotic stewardship policy in the Nancy Teaching Hospital. Med Mal Infect 2011; 41:532-9; PMID:21907511; http://dx.doi.org/10.1016/j.medmal.2011.08.001
11. Rattanaumpawan P, Morales KH, Binkley S, Synnestvedt M, Weiner MG, Gasink LB, et al. Impact of antimicrobial stewardship programme changes on unnecessary double anaerobic coverage therapy. J Antimicrob Chemother 2011; 66:2655-8; PMID:21803769; http://dx.doi.org/10.1093/jac/dkr321
12. Griffith M, Postelnick M, Scheetz M. Antimicrobial stewardship programs: methods of operation and suggested outcomes. Expert Rev Anti Infect Ther 2012; 10:63-73; PMID:22149615; http://dx.doi.org/10.1586/eri.11.153
13. Cunha BA. Effective antibiotic-resistance control strategies. Lancet 2001; 357:1307-8; PMID:11343730; http://dx.doi.org/10.1016/S0140-6736(00)04527-X
14. Aldeyab MA, Harbarth S, Vernaz N, Kearney MP, Scott MG, Darwish Elhajji FW, et al. The impact of antibiotic use on the incidence and resistance pattern of extended-spectrum beta-lactamase-producing bacteria in primary and secondary healthcare settings. Br J Clin Pharmacol 2012; 74:171-9; PMID:22150975; http://dx.doi.org/10.1111/j.1365-2125.2011.04161.x
15. Rice LB. Mechanisms of resistance and clinical relevance of resistance to b-lactams, glycopeptides, and fluoroquinolones. Mayo Clin Proc 2012; 87:198-208; PMID:22305032; http://dx.doi.org/10.1016/j.mayocp.2011.12.003
16. Doron S, Davidson LE. Antimicrobial stewardship. Mayo Clin Proc 2011; 86:1113-23; PMID:22033257; http://dx.doi.org/10.4065/mcp.2011.0358
17. Ohl CA, Dodds Ashley ES. Antimicrobial stewardship programs in community hospitals: the evidence base and case studies. Clin Infect Dis 2011; 53(Suppl 1):S23-8, quiz S29-30; PMID:21795725; http://dx.doi.org/10.1093/cid/cir365
18. Chung GW, Wu JE, Yeo CL, Chan D, Hsu LY. Antimicrobial stewardship: A review of prospective audit and feedback systems and an objective evaluation of outcomes. Virulence 2013; In press; PMID:23302793; http://dx.doi.org/10.4161/viru.21626
19. Reed EE, Stevenson KB, West JE, Bauer KA, Goff DA. Impact of formulary restriction with prior authorization by an antimicrobial stewardship program. Virulence 2012; In press; PMID:23154323; http://dx.doi.org/10.4161/viru.21657
20. Höjgård S. Antibiotic resistance-why is the problem so difficult to solve? Infect Ecol Epidemiol 2012; 2:; PMID:22957126; http://dx.doi.org/10.3402/iee.v2i0.18165
21. Landelle C, Pagani L, Harbarth S. Is patient isolation the single most important measure to prevent the spread of multidrug-resistant pathogens? Virulence 2013; In press; PMID:23302791; http://dx.doi.org/10.4161/viru.22641
22. Bhattacharya S. Early diagnosis of resistant pathogens: How can it improve antimicrobial treatment? Virulence 2013; In press; PMID:23302786; http://dx.doi.org/10.4161/viru.23326
23. Jonas D, Speck M, Daschner FD, Grundmann H. Rapid PCR-based identification of methicillin-resistant Staphylococcus aureus from screening swabs. J Clin Microbiol 2002; 40:1821-3; PMID:11980967; http://dx.doi.org/10.1128/JCM.40.5.1821-1823.2002
24. Gould IM, Bal AM. New antibiotic agents in the pipeline and how they can help overcome microbial resistance. Virulence 2013; In press; PMID:23302792; http//dx.doi.org/10.4161/viru.22507
25. Cunha BA. Oral doxycycline for non-systemic urinary tract infections (UTIs) due to P. aeruginosa and other Gram negative uropathogens. Eur J Clin Microbiol Infect Dis 2012; 31:2865-8; PMID:22767268; http://dx.doi.org/10.1007/s10096-012-1680-0
26. Talpaert MJ, Gopal Rao G, Cooper BS, Wade P. Impact of guidelines and enhanced antibiotic stewardship on reducing broad-spectrum antibiotic usage and its effect on incidence of Clostridium difficile infection. J Antimicrob Chemother 2011; 66:2168-74; PMID:21676904; http://dx.doi.org/10.1093/jac/dkr253
27. Pulcini C, Gyssens IC. How to educate prescribers in antimicrobial stewardship practices. Virulence 2013; In press; PMID:23361336; http://dx.doi.org/10.4161/viru.23706
28. Sepkowitz KA. Finland, Weinstein, and the birth of antibiotic regret. N Engl J Med 2012; 367:102-3; PMID:22784113; http://dx.doi.org/10.1056/NEJMp1205847